Candida auris in healthcare settings
Due to its propensity to cause outbreaks and its antifungal resistance, C. auris poses a risk for patients in healthcare facilities in Europe. Difficulties with laboratory identification, combined with a lack of awareness of this new Candida species, might result in unnoticed outbreaks. There is a clear need to raise awareness in European healthcare facilities in order adapt laboratory testing strategies and implement enhanced control measures to prevent further hospital outbreaks.
Data on the daily number of new reported COVID-19 cases and deaths by EU/EEA country
The downloadable data file is updated daily and contains the latest available public data on COVID-19. Each row/entry contains the number of new cases and deaths reported per day and per country in the EU/EEA.Read more
Communicable disease threats report, 19-25 September 2021, week 38
24 Sep 2021 - The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 19-25 September 2021 and includes updates on COVID-19, West Nile virus, Marburg virus disease and Cholera.
West Nile virus in Europe in 2021 - human cases, updated 23 September 2021
Between 17 and 23 September 2021, European Union (EU) and European Economic Area (EEA) countries reported 9 human cases of West Nile virus (WNV) infection and 1 deaths related to WNV infections. Cases were reported by Greece (5) and Italy (4). Deaths were reported by Greece (1). EU-neighbouring countries reported 2 human cases of WNV infection in Serbia (2) and no deaths related to WNV infections.Read more